TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RLAY

Relay Therapeutics Inc

Healthcare · Biotechnology

19.40$ +6.4% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RLAY
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-8.3% +103.5% +26.1% +9.1% -23.3% +3.2% -28.7%
-15.0% +113.6% +26.8% +4.4% -24.5% +5.1% -28.5%
-90.0% +967.0% -37.4% -45.8% -5.3% -13.5% -32.4%
-15.6% +90.6% +41.3% +4.3% -24.9% +4.2% -29.0%
-94.0% +5.6% -100.0%
+771.8% -8.9% -77.3% +77.8%
+0.0% +0.0% +0.0%
+6.3% -93.6% +202.8% +35.2% -38.5% +1.7% -42.0%
+74.6% +13.7% +78.4% +162.0% -52.5% +67.6% -49.6%
+601.7% +21.8% +21.2% +131.9% +16.1% +15.4% -34.3%
+48.6% -9.2% +30.3% +27.8% -12.9% +53.0% -45.3%
+17.6% +5.8% -20.9% +3.4% -27.1%
+72.3% +2,006.6% +5.5% +18.0% +9.2% +16.6% +20.1%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?